Modified release hydrocortisone capsules (MRHC, Efmody) improve control of congenital adrenal hyperplasia (CAH) on a lower glucocorticoid dose than standard treatment
Year: 2022
Type: conference-abstract
Source: Endocrine Abstracts
Authors: Aled Rees, Deborah P Merke, Wiebke Arlt, De La Periere Aude Brac, Hirschberg Angelica Linden, Anders Juul, Ashwini Mallappa, John D. C. Newell-Price, Perry Colin Graham, Alessandro Prete, Nicole Reisch, Monica Stikkelbroeck, Philippe A Touraine, Helen Coope, John Porter, Richard John M Ross
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4229365372
